A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.

Creator(s)

J Kevin Hicks
Jeffrey R. Bishop
Roseann S. Gammal
Katrin Sangkuhl
Chad A. Bousman
J Steven Leeder, Children's Mercy HospitalFollow
Adrián Llerena
Daniel J. Mueller
Laura B. Ramsey
Stuart A. Scott
Todd C. Skaar
Kelly E. Caudle
Teri E. Klein
Andrea Gaedigk, Children's Mercy HospitalFollow

Document Type

Article

Publication Date

1-2020

Identifier

DOI: 10.1002/cpt.1661

Journal Title

Clinical pharmacology and therapeutics

Volume

107

Issue

1

First Page

50

Last Page

52

MeSH Keywords

Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Labeling; Humans; Marketing of Health Services; Pharmacogenetics; Pharmacogenomic Testing; Precision Medicine; Sertraline

Keywords

Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Labeling; Humans; Marketing of Health Services; Pharmacogenetics; Pharmacogenomic Testing; Precision Medicine; Sertraline

Comments

Grant support

• R24 GM061374/GM/NIGMS NIH HHS/United States
• R24 GM115264/GM/NIGMS NIH HHS/United States
• R01 HD089928/HD/NICHD NIH HHS/United States
• R21 AT009475/AT/NCCIH NIH HHS/United States
• P30 CA076292/CA/NCI NIH HHS/United States

• R24 GM123930/GM/NIGMS NIH HHS/United States
• P50 HD090258/HD/NICHD NIH HHS/United States
• U24 HG010135/HG/NHGRI NIH HHS/United States
• U54 HD090258/HD/NICHD NIH HHS/United States

Recommended Citation

Hicks JK, Bishop JR, Gammal RS, et al. A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy. Clin Pharmacol Ther. 2020;107(1):50-52. doi:10.1002/cpt.1661